|Leading policy-makers and scholars explain how market forces, deregulation, and consumer choice can work to improve health care for all Americans.||
Pharmaceuticals and the Worldwide HIV Epidemic: Can a Stakeholder Model Work?
The global AIDS pandemic has led many activists to call for scrapping the current system of pharmaceutical intellectual property rights and profit-driven innovation. Bates and Calfee argue that shifting the industry to a public interest or "stakeholder" model of drug development would likely undermine essential R&D while doing little to affect the spread of AIDS.
|home spotlight commentary research events news about contact links archives|